ReviewTransplantation
Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation
- 1Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN 55455, USA.
- 2Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA.3Immune Tolerance Network, Massachusetts General Hospital, Boston, MA 02114, USA.
- ↵†Corresponding author. E-mail: blaza001{at}umn.edu (B.R.B.); lturka{at}partners.org (L.A.T.)
↵* These authors share senior authorship.
See allHide authors and affiliations
Science Translational Medicine 25 Mar 2015:
Vol. 7, Issue 280, pp. 280rv2
DOI: 10.1126/scitranslmed.aaa6853
Vol. 7, Issue 280, pp. 280rv2
DOI: 10.1126/scitranslmed.aaa6853
Cameron McDonald-Hyman
1Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN 55455, USA.
Laurence A. Turka
2Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA.3Immune Tolerance Network, Massachusetts General Hospital, Boston, MA 02114, USA.
2Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA.3Immune Tolerance Network, Massachusetts General Hospital, Boston, MA 02114, USA.
Bruce R. Blazar
1Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN 55455, USA.
